Gartner Says the Applications of 3D Printing Will Ignite a Major Debate on Ethics and Regulation
The Rapid Development of 3D Bioprinters Will Spark Calls to Ban the Technology for Human and Nonhuman Use by 2016
Our key point was not lost in the coverage: The technology of 3D ‘bioprinting’ (that is, the medical application of 3D printing to produce living tissue and organs) is advancing so quickly that it will spark a major ethical debate on its use by 2016.
Some people have been asking “Why?” They suggest that only good could come from such medical applications.
And, in an ideal, pure world they would be right. But we don’t live in such a world, do we? For the hundreds and thousands of researchers fighting for a cure, there may be one who is not.
Consider another side to bioprinting. The Complex heterogeneous tissue constructs containing multiple cell types prepared by inkjet printing technology study, which combined human and animal cells, demonstrated “the feasibility of fabricating complex heterogeneous tissue constructs containing multiple cell types using inkjet printing technology.” While demonstrating yet another advancement in inkjet printing technology, the key point is that the combination of human and animal cells happened without general public awareness.
And that will ignite the debate among people who have ethical, moral, religious and even political concerns with such human/animal bioprinted combinations.
So, what do we do?
We continue to do good bioprinting research and we simultaneously consider the meaning of this work. What are the ethical, moral, religious and political implications of the work that is being done?
Those questions must be asked now, not once the research is complete.
What is your opinion?
Read Complimentary Relevant Research
Top Strategic Predictions for 2019 and Beyond: Practicality Exists Within Instability
Technology-based change is happening continuously, and most organizations struggle to see the change in advance. Continuous change can...
View Relevant Webinars
Comments or opinions expressed on this blog are those of the individual contributors only, and do not necessarily represent the views of Gartner, Inc. or its management. Readers may copy and redistribute blog postings on other blogs, or otherwise for private, non-commercial or journalistic purposes, with attribution to Gartner. This content may not be used for any other purposes in any other formats or media. The content on this blog is provided on an "as-is" basis. Gartner shall not be liable for any damages whatsoever arising out of the content or use of this blog.